NCT03849612View on ClinicalTrials.gov

A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 21, 2019

Primary Completion Date

March 27, 2019

Study Completion Date

March 27, 2019

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

AID System

AID system

DRUG

Insulin Lispro

Individualized doses of insulin lispro administered via the AID system to maintain glycemic control, except during procedures designed to induce hyperglycemia and hypoglycemia.

Trial Locations (1)

94598

Diablo Clinical Research, Walnut Creek

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03849612 - A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter